KLK3 and posterior cortical atrophy: Interestingly, there was no difference in PSA levels between patients with and without BOO in both overall population and patients with PSA ≤ 10 ng/mL, further supporting the concept that, for the same PSA level, the likelihood of being diagnosed with PCa is much greater for the nonobstructed than for the obstructed patients.